• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期非小细胞肺癌调强(化疗)放疗中放射性急性食管炎的临床、剂量学和位置因素

Clinical, dosimetric, and position factors for radiation-induced acute esophagitis in intensity-modulated (chemo)radiotherapy for locally advanced non-small-cell lung cancer.

作者信息

Huang Jin, He Tianyu, Yang Ronghui, Ji Tianlong, Li Guang

机构信息

Department of Radiotherapy, The First Hospital of China Medical University, Shenyang 110001, China,

Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110000, China.

出版信息

Onco Targets Ther. 2018 Sep 21;11:6167-6175. doi: 10.2147/OTT.S174561. eCollection 2018.

DOI:10.2147/OTT.S174561
PMID:30288052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6160279/
Abstract

PURPOSE

The purpose of this study was to estimate the relation between acute esophagitis (AE) and clinical, dosimetric, and position factors in patients with locally advanced non-small-cell lung cancer (NSCLC) receiving intensity-modulated (chemo)radiotherapy.

MATERIALS AND METHODS

A retrospective cohort analysis was performed to identify factors associated with Common Toxicity Criteria for Adverse Events grade 2 or worse AE (AE2+). A multivariable model was established including patient- and treatment-related variables and esophageal dose-volume histogram parameters. The esophagus was divided according to physiological anatomy, and logistic regression was used to analyze the position parameter for its correlation with AE2+.

RESULTS

The incidence of AE2+ was 27.5%. All models included gender, concurrent chemo-radiotherapy (CCRT), position parameter, and one of the dosimetric variables. The model with mean dose showed the best goodness of fit. Gender (OR=2.47, =0.014), CCRT (OR=3.67, =0.015), mean dose (OR=1.33, <0.001), and maximum radiation position (OR=1.65, =0.016) were significantly related to AE2+.

CONCLUSION

Gender, concurrent chemotherapy, maximum radiation position, and mean dose were independent risk factors for AE2+. The upper part of the esophagus showed a higher sensitivity to radiation toxicity.

摘要

目的

本研究旨在评估接受调强(化疗)放疗的局部晚期非小细胞肺癌(NSCLC)患者中急性食管炎(AE)与临床、剂量学及体位因素之间的关系。

材料与方法

进行一项回顾性队列分析,以确定与不良事件通用毒性标准2级或更严重AE(AE2+)相关的因素。建立了一个多变量模型,包括患者和治疗相关变量以及食管剂量体积直方图参数。根据生理解剖结构对食管进行划分,并使用逻辑回归分析体位参数与AE2+的相关性。

结果

AE2+的发生率为27.5%。所有模型均包括性别、同步放化疗(CCRT)、体位参数以及一个剂量学变量。平均剂量模型显示出最佳的拟合优度。性别(OR=2.47,P=0.014)、CCRT(OR=3.67,P=0.015)、平均剂量(OR=1.33,P<0.001)以及最大放射部位(OR=1.65,P=0.016)与AE2+显著相关。

结论

性别、同步化疗、最大放射部位和平均剂量是AE2+的独立危险因素。食管上段对放射毒性表现出更高的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6245/6160279/df541516bbd2/ott-11-6167Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6245/6160279/df541516bbd2/ott-11-6167Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6245/6160279/df541516bbd2/ott-11-6167Fig1.jpg

相似文献

1
Clinical, dosimetric, and position factors for radiation-induced acute esophagitis in intensity-modulated (chemo)radiotherapy for locally advanced non-small-cell lung cancer.局部晚期非小细胞肺癌调强(化疗)放疗中放射性急性食管炎的临床、剂量学和位置因素
Onco Targets Ther. 2018 Sep 21;11:6167-6175. doi: 10.2147/OTT.S174561. eCollection 2018.
2
Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy.同步放化疗治疗局部晚期非小细胞肺癌患者的急性食管炎。
Radiother Oncol. 2016 Mar;118(3):465-70. doi: 10.1016/j.radonc.2016.01.007. Epub 2016 Jan 20.
3
Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.晚期非小细胞肺癌患者接受调强(化疗)放疗后急性食管毒性的多变量正常组织并发症建模
Radiother Oncol. 2015 Oct;117(1):49-54. doi: 10.1016/j.radonc.2015.08.010. Epub 2015 Sep 2.
4
Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.接受三维适形放疗的非小细胞肺癌患者放射性食管毒性的预测因素
Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):337-41. doi: 10.1016/s0360-3016(02)03937-8.
5
Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.非小细胞肺癌患者高剂量适形放疗后的急性食管毒性
Radiother Oncol. 2005 May;75(2):157-64. doi: 10.1016/j.radonc.2005.03.021.
6
Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.肺癌放疗患者急性食管炎的剂量学相关因素
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1106-13. doi: 10.1016/j.ijrobp.2003.09.080.
7
Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.三维适形放疗治疗非小细胞肺癌患者急性食管炎的临床和剂量学危险因素。
Am J Clin Oncol. 2010 Jun;33(3):271-5. doi: 10.1097/COC.0b013e3181a879e0.
8
Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.局部晚期非小细胞肺癌的个体化剂量处方:已发表的正常组织并发症概率模型的验证。
Radiother Oncol. 2019 Sep;138:45-51. doi: 10.1016/j.radonc.2019.05.011. Epub 2019 May 27.
9
Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.肺癌患者调强放疗及同期化疗后的急性食管毒性
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e223-8. doi: 10.1016/j.ijrobp.2012.03.027. Epub 2012 May 5.
10
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).接受剂量差异化加速放疗(DART - bid)治疗的患者中,与临床相关的急性食管炎(≥2级)的正常组织并发症模型。
Radiat Oncol. 2015 May 28;10:121. doi: 10.1186/s13014-015-0429-1.

引用本文的文献

1
Research progress of radiation esophagitis: A narrative review.放射性食管炎的研究进展:一篇叙述性综述。
Medicine (Baltimore). 2025 May 9;104(19):e42273. doi: 10.1097/MD.0000000000042273.
2
Radiomic and dosimetric parameter-based nomogram predicts radiation esophagitis in patients with non-small cell lung cancer undergoing combined immunotherapy and radiotherapy.基于放射组学和剂量学参数的列线图预测接受免疫治疗联合放疗的非小细胞肺癌患者放射性食管炎的发生。
Front Oncol. 2024 Dec 18;14:1490348. doi: 10.3389/fonc.2024.1490348. eCollection 2024.
3
Association of Radiation-Induced Acute Esophagitis With Dosimetric Parameters of Oesophagus in Breast Carcinoma Patients Receiving Supraclavicular Nodal Irradiation.

本文引用的文献

1
Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.对于接受调强(化疗)放疗的晚期非小细胞肺癌患者,食管壁剂量-表面图并不能提高多变量正常组织并发症概率(NTCP)模型对急性食管毒性的预测性能。
Phys Med Biol. 2017 May 7;62(9):3668-3681. doi: 10.1088/1361-6560/aa5e9e. Epub 2017 Apr 5.
2
Predictors for severe acute esophagitis in lung cancer patients treated with chemoradiotherapy: a systematic review.接受放化疗的肺癌患者发生严重急性食管炎的预测因素:一项系统评价
Curr Med Res Opin. 2016 Oct;32(10):1701-1708. doi: 10.1080/03007995.2016.1205004. Epub 2016 Jul 20.
3
接受锁骨上淋巴结照射的乳腺癌患者放射性急性食管炎与食管剂量学参数的相关性
Cureus. 2024 May 21;16(5):e60778. doi: 10.7759/cureus.60778. eCollection 2024 May.
4
Dosimetric risk factors for radiation esophagitis in patients with breast cancer following regional nodal radiation.乳腺癌患者区域淋巴结放疗后放射性食管炎的剂量学危险因素。
World J Clin Cases. 2024 Jun 16;12(17):2995-3003. doi: 10.12998/wjcc.v12.i17.2995.
5
Head and Neck Radiation Therapy Patterns of Practice Variability Identified as a Challenge to Real-World Big Data: Results From the Learning from Analysis of Multicentre Big Data Aggregation (LAMBDA) Consortium.头颈部放射治疗实践模式的变异性被视为现实世界大数据面临的挑战:多中心大数据聚合分析(LAMBDA)联盟的研究结果
Adv Radiat Oncol. 2022 Feb 23;8(1):100925. doi: 10.1016/j.adro.2022.100925. eCollection 2023 Jan-Feb.
6
Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy.利用炎症指标和临床参数预测接受放化疗的小细胞肺癌患者的放射性食管炎。
Front Oncol. 2022 Nov 22;12:898653. doi: 10.3389/fonc.2022.898653. eCollection 2022.
7
Radiation-Induced Esophagitis in Non-Small-Cell Lung Cancer Patients: Voxel-Based Analysis and NTCP Modeling.非小细胞肺癌患者放射性食管炎:基于体素的分析和正常组织并发症概率模型
Cancers (Basel). 2022 Apr 5;14(7):1833. doi: 10.3390/cancers14071833.
8
Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients.在非小细胞肺癌患者独立队列中与放射性食管炎风险相关的多态性验证
Cancers (Basel). 2021 Mar 22;13(6):1447. doi: 10.3390/cancers13061447.
Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy.
同步放化疗治疗局部晚期非小细胞肺癌患者的急性食管炎。
Radiother Oncol. 2016 Mar;118(3):465-70. doi: 10.1016/j.radonc.2016.01.007. Epub 2016 Jan 20.
4
Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.晚期非小细胞肺癌患者接受调强(化疗)放疗后急性食管毒性的多变量正常组织并发症建模
Radiother Oncol. 2015 Oct;117(1):49-54. doi: 10.1016/j.radonc.2015.08.010. Epub 2015 Sep 2.
5
The initial establishment and epithelial morphogenesis of the esophagus: a new model of tracheal-esophageal separation and transition of simple columnar into stratified squamous epithelium in the developing esophagus.食管的初始建立和上皮形态发生:气管食管分离及发育中食管单层柱状上皮向复层鳞状上皮转变的新模型
Wiley Interdiscip Rev Dev Biol. 2015 Jul-Aug;4(4):419-30. doi: 10.1002/wdev.179. Epub 2015 Feb 27.
6
Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy.接受同步放化疗的非小细胞肺癌患者放射性急性食管炎的危险因素。
Radiat Oncol. 2014 Feb 15;9:54. doi: 10.1186/1748-717X-9-54.
7
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.预测非小细胞肺癌放化疗后食管炎:一项个体患者数据荟萃分析。
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):690-6. doi: 10.1016/j.ijrobp.2013.07.029. Epub 2013 Sep 10.
8
Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy.土耳其接受放射治疗的肺癌患者急性食管炎的剂量学和临床预测因素
Asian Pac J Cancer Prev. 2013;14(7):4223-8. doi: 10.7314/apjcp.2013.14.7.4223.
9
Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer.调强放疗同步化疗治疗局部晚期非小细胞肺癌的急性食管毒性的预后参数。
Radiother Oncol. 2013 Jun;107(3):392-7. doi: 10.1016/j.radonc.2013.04.012. Epub 2013 May 3.
10
Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose.对于有淋巴结受累的 NSCLC 患者,不均匀剂量递增可提高局部控制率,而不会增加平均肺剂量。
Acta Oncol. 2014 Jan;53(1):119-25. doi: 10.3109/0284186X.2013.790560. Epub 2013 Apr 29.